MGRC | MSIAN GENOMICS RES CENTRE BHD
0.300 (0.0%)
Last updated: 17:00
iSaham Fundamental Trend - MGRC
FCON: 0.5 | LTS: 4.67
Financial Ratios - MGRC
| Trailing PE (Sector Median: 17.3) | 0.0 |
| EV/EBITDA (Sector Median: 11.4) | 0.0 |
| PEG | -0.0 |
| Sharpe Ratio (3-yrs) | -0.14 |
| Altman Z | 1.1 |
| Beaver | -0.295 |
| Current Ratio | 2.59 |
| Debt-Equity (DE) Ratio | 1.07 |
| FCF Yield | -27.24 % |
| Revenue QoQ | 0.3 % |
| Profit QoQ | -22.65 % |
| Profit YoY | -217.79 % |
| NTA QoQ | -19.59 % |
| Profit Margin (Sector Median: 2.6) | -16.5 % |
| ROE | -20.58 % |
| ROIC | -14.89 % |
| Dividend Per Share (DPS) | 0.0 sen |
| Dividend Yield (DY) | 0.0 % |
Support & Resistance
ATR Trailing Stop: 0.29
| Price | 0.24 | 0.25 | 0.255 | 0.26 | 0.3 | 0.3 | 0.3 | 0.305 | 0.31 | 0.32 | 0.33 |
| Volume (M) | 0.3 | 0.2 | 0.1 | 0.1 | 0.3 | 0.3 | 0.0 | 0.0 | 0.1 | 0.1 | |
Gann Support (EP/CL): 0.28/0.25 | Resistance (TP): 0.31/0.34
iGann Support (EP/CL): 0.28/0.25 | Resistance (TP): 0.32/0.35
*Highlighted column shows significant volume at the support or resistance area.
Technical Trend
Moving Average Trend
Volume Trend
Trading Signalsbeta - MGRC
Based on iSaham Screeners
| Moving Average (Short Term) | BUY |
| Moving Average (Mid Term) | BUY |
| Moving Average (Long Term) | BUY |
| Ichimoku Kumo | BUY |
| Bollinger Band | - |
| RSI | BUY |
| Stochastic | BUY |
| Heikin-Ashi | HOLD |
| MACD | BUY (Above 0) |
| Solid MA Trend | - |
| SAT | SELL |
| Sector Trend (Long Term) | SELL |
| Sector Trend (Short Term) | SELL |
| Institutional Holdings | - |
| Beat The Insti | - |
| Magic Formula | SELL |
| Better Than ASB | - |
| 52-Week High | - |
| BTST | - |
| T+ | - |
| Candlestick | - |
| Chart Pattern | - |
Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.
Fair Value
iSaham Fair Value: -0.115
| Discounted Cash Flow (DCF)5.0% Growth | -0.35 |
| Discounted Cash Flow (DCF)-20.6% Growth | -0.115 |
| Relative Valuation | 0.0 |
| Graham Formula | -0.31 |
| Graham Number | 0.0 |
| Net Tangible Asset MA | 0.19 |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0.0 |
| Expected Revenue (M) | 0.0 |
| Expected Growth (%) | 0.0 |
Summary
Market Cap: 30 M.
Number of Shares: 103 M.
Float: Not Available.
Stock highly correlated with
GESHEN (95%)
TAWIN (95%)
SALUTE (94%)
FIHB (93%)
MGRC provides genome sequencing and analysis services. Our services and pipelines are designed to rapidly sequence and analyse large volumes of genetic data and extract meaningful biological information for downstream research and development. The key components of our commercial operations are our Contract Genomics Services, Sequencing Services, and Data and Access Services. Our services and applications have been used extensively in significant projects, including the mapping of the lung cancer genome, and the sequencing and assembly of the oil palm genome. To date, the company have undertaken projects for large agriculture-based companies, major medical research institutions, and government linked or funded entities in Malaysia and abroad, including United States and Australia. Currently, MGRC are the only player in Malaysia providing commercial bioinformatics analysis services for data from multiple second and third generation sequencing machines, serving public and private sector organizations in Malaysia and internationally. They have established themselves as Malaysia's leading provider of Contract Genomics Services
Code: 0155
Website: http://www.mgrc.com.my/
Related Links: Bursa | Analyst Report | Annual Report | Announcement
Top Shareholdings
| Shareholder | Value (M) |
|---|---|
| Synamatix Sdn Bhd | 17.51 |
| Koh Kin Lip | 1.56 |
| Neuramatix Sdn Bhd | 1.25 |
| Mohd Rafael bin Mohd Shamsudin | 0.99 |
| Zharif Omar bin Mohamed Radzif | 0.87 |
| Munirah binti Haji Abdul Hamid | 0.87 |
| Mah Siew Hoe | 0.81 |
| Nor Azah binti Adnan | 0.76 |
| Inertia AIF Sdn Bhd | 0.4 |
| Loh Chai Keong | 0.36 |
| Mohamed Roslan bin Mohamed Shamsudin | 0.36 |
| Lai Thiam Poh | 0.32 |
| Fortress Capital Asset Management (M) Sdn Bhd | 0.3 |
| Shahril bin Shamsuddin | 0.3 |
| Teong Teck Lean | 0.3 |
| Encipta Ltd | 0.26 |
| Mohamed Radzif bin Mohamed Shamsudin | 0.23 |
| Nor Azizan binti Adnan | 0.21 |
| Lim Kian Wat | 0.19 |
| Maznah binti Ali | 0.16 |
| Noraziah binti Adnan | 0.15 |
| S. Elias bin Abd. Rahman Alhabshi | 0.15 |
| A Aziz bin Mohd Isa | 0.14 |
| Kamarudin bin Meranun | 0.12 |
| Azlan Shairi bin Asidin | 0.11 |
| Rupee Enterprise Sdn Bhd | 0.1 |
| Che Onn bin Ismail | 0.08 |
| Razali bin Manap | 0.07 |